PT - JOURNAL ARTICLE AU - Yang, Xiaochen AU - Sullivan, Patrick F. AU - Li, Bingxuan AU - Fan, Zirui AU - Ding, Dezheng AU - Shu, Juan AU - Guo, Yuxin AU - Paschou, Peristera AU - Bao, Jingxuan AU - Shen, Li AU - Ritchie, Marylyn D. AU - Nave, Gideon AU - Platt, Michael L. AU - Li, Tengfei AU - Zhu, Hongtu AU - Zhao, Bingxin TI - Multi-organ imaging-derived polygenic indexes for brain and body health AID - 10.1101/2023.04.18.23288769 DP - 2024 Jan 01 TA - medRxiv PG - 2023.04.18.23288769 4099 - http://medrxiv.org/content/early/2024/06/03/2023.04.18.23288769.short 4100 - http://medrxiv.org/content/early/2024/06/03/2023.04.18.23288769.full AB - The UK Biobank (UKB) imaging project is a crucial resource for biomedical research, but is limited to 100,000 participants due to cost and accessibility barriers. Here we used genetic data to predict heritable imaging-derived phenotypes (IDPs) for a larger cohort. We developed and evaluated 4,375 IDP genetic scores (IGS) derived from UKB brain and body images. When applied to UKB participants who were not imaged, IGS revealed links to numerous phenotypes and stratified participants at increased risk for both brain and somatic diseases. For example, IGS identified individuals at higher risk for Alzheimer’s disease and multiple sclerosis, offering additional insights beyond traditional polygenic risk scores of these diseases. When applied to independent external cohorts, IGS also stratified those at high disease risk in the All of Us Research Program and the Alzheimer’s Disease Neuroimaging Initiative study. Our results demonstrate that, while the UKB imaging cohort is largely healthy and may not be the most enriched for disease risk management, it holds immense potential for stratifying the risk of various brain and body diseases in broader external genetic cohorts.Competing Interest StatementThe authors have declared no competing interest.Funding StatementResearch reported in this publication was supported by the National Institute On Aging of the National Institutes of Health under Award Number RF1AG082938. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The study has also been partially supported by funding from the Wharton Dean's Research Fund, Analytics at Wharton, and Purdue Statistics Department.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The individual-level data used in the present study have been openly available from the UK Biobank (https://www.ukbiobank.ac.uk/) study.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes